United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$230Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Google Ventures
Alexandria Real Estate Equities
Merck Global Health Innovation Fund
Arch
Boyu Capital
Blue Pool CapitalReported by FinSMEsSEC filing: $25M sold, first sale Sept 2017
From the SEC filings it signed: 2 on the team.
On the board, as filediKrishna L. YeshwantRichard L. KlausnerWei L. LiYanling L. Cao
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Google VenturesFidelity
ARCH Venture Partners
Foresite CapitalAlexandria Real Estate EquitiesMerck Global Health Innovation FundArchBoyu CapitalBlue Pool CapitalWuXi Healthcare Ventures/ ForesiteMissing a round, or an investor who was in one? Tell us.
LifeMine Therapeutics's investors include Google Ventures, Fidelity, ARCH Venture Partners, Foresite Capital and Alexandria Real Estate Equities, and 5 more on record.
LifeMine Therapeutics has raised $230M across 2 rounds since 2017.
LifeMine Therapeutics's most recent round was a Series C of $175M in Mar 2022.
Its most recent round, $175M in Mar 2022, is also its largest on record.
LifeMine Therapeutics's first round on record, in Sept 2017, was backed by Google Ventures, Alexandria Real Estate Equities and Merck Global Health Innovation Fund and 4 others.
LifeMine Therapeutics's latest named round is a Series C, in Mar 2022.
LifeMine Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
